Zio XT ECG Monitoring System vs 1CMR Pro

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by iRhythm Technologies
VS
by Mycardium AI Limited

AI Verdict

Tool A, the Zio XT ECG Monitoring System, focuses on continuous, long-term cardiac monitoring via a wearable biosensor to detect arrhythmias. In contrast, Tool B, 1CMR Pro, is an AI-enhanced software designed for analyzing and reporting on Cardiac MRI images, providing precise volumetric and functional measurements. While both leverage AI in cardiology, they address distinct diagnostic modalities and clinical workflows, making them complementary rather than direct competitors.

Choose Zio XT ECG Monitoring System if…

Choose Zio XT if you need a highly compliant and comfortable solution for extended ambulatory cardiac monitoring, particularly for detecting intermittent arrhythmias over several days. Its wearable, lead-free design and AI-powered analysis provide accurate diagnoses with minimal patient burden, ideal for outpatient settings.

View Zio XT ECG Monitoring System →

Choose 1CMR Pro if…

Choose 1CMR Pro if your cardiology or radiology department requires advanced, AI-enhanced analysis for Cardiac MRI scans, prioritizing precision, speed, and consistency in reporting. This on-premise software ensures local data processing and offers regulatory-grade automation for highly accurate volumetric and functional measurements.

View 1CMR Pro →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Zio XT ECG Monitoring System 1CMR Pro
Pricing Contact for pricing Contact for pricing
Deployment Cloud-based (AWS EC2 platform), no on-premise hardware required. On-premise (software installed on hospital's own computer, processing data locally via a secure web-based platform)
BAA Available Yes AI-estimated Unknown
FDA Status Yes AI-estimated 1 AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Zio XT ECG Monitoring System

Tool A, Zio XT, demonstrates strong patient usability with its wearable, wire-free, water-resistant design, leading to high patient compliance (up to 99%). While Tool B, 1CMR Pro, enhances clinician workflow, Tool A's focus on patient comfort for data collection makes its usability claims more broadly impactful for its primary users.

Clinical Value

1CMR Pro

Tool B, 1CMR Pro, offers a highly quantifiable clinical benefit by delivering up to 40% more precise measurements in Cardiac MRI analysis, enhancing diagnostic accuracy and consistency. While Tool A provides crucial arrhythmia detection, Tool B's specific, measurable improvement in a complex diagnostic modality gives it a slight edge in demonstrable clinical impact.

Pricing & Value

Zio XT ECG Monitoring System

Tool A, Zio XT, provides transparent and publicly disclosed pricing for key markets (UK and US Medicare), allowing healthcare providers to easily assess costs and potential reimbursement. In contrast, Tool B, 1CMR Pro, has undisclosed, likely enterprise-based pricing, making it difficult to evaluate its value proposition without direct inquiry.

Enterprise Readiness

Zio XT ECG Monitoring System

Tool A, Zio XT, is cloud-based (AWS EC2), requires no on-premise hardware, and explicitly states HIPAA compliance with a BAA, simplifying deployment and regulatory adherence for large enterprises. While Tool B's on-premise local data processing is a strong security feature, its deployment model can be more complex for IT, and explicit HIPAA compliance for the product was not stated.

Innovation

1CMR Pro

Tool B, 1CMR Pro, demonstrates a higher degree of innovation by applying advanced AI (convolutional neural networks trained on extensive datasets) to achieve 'regulatory-grade automation' and 'up to 40% higher precision' in the complex field of Cardiac MRI analysis. This represents a significant leap in quantitative imaging diagnostics.

Support & Docs

Tie

The provided structured facts and available public information do not offer specific details regarding the level or type of customer support and documentation for either Zio XT or 1CMR Pro. Therefore, it is not possible to distinguish between the two on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Zio XT ECG Monitoring System 1CMR Pro
Tool Name Zio XT ECG Monitoring System 1CMR Pro
Company iRhythm Technologies Mycardium AI Limited
Primary Modality/Function Wearable single-lead ECG biosensor for continuous cardiac monitoring AI-enhanced Cardiac MRI reporting software
Data Processing Location Cloud-based software platform (ZEUS) Local data processing (no patient data transmitted beyond institution)
Monitoring/Analysis Duration Continuous ambulatory cardiac monitoring for up to 14 days Not specified
Key AI Application Proprietary, FDA-cleared deep-learned AI algorithm for ECG data analysis AI-enhanced Cardiac MRI Reporting, automated volumetric and functional measurements

Videos

Demos, reviews, and walkthroughs featuring Zio XT ECG Monitoring System and 1CMR Pro.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Zio XT is designed for continuous ambulatory ECG monitoring to detect arrhythmias in patients requiring extended rhythm assessment. 1CMR Pro, conversely, focuses on enhancing the precision and speed of cardiac MRI analysis for structural and functional heart conditions.
Zio XT involves patients wearing a biosensor, with physicians primarily reviewing cloud-based, AI-generated, and expert-validated reports. 1CMR Pro integrates directly into the cardiac MRI analysis workflow, providing automated measurements with editable contours that clinicians would learn to review and adjust.
Zio XT utilizes a deep-learned AI algorithm and expert review for accurate arrhythmia detection over extended periods, improving diagnostic yield. 1CMR Pro delivers up to 40% higher precision in cardiac MRI measurements and regulatory-grade automation, enhancing the reproducibility and consistency of cardiac assessments.
Zio XT uses a cloud-based platform (AWS EC2) for data storage and analysis, leveraging a major cloud provider's security infrastructure. 1CMR Pro processes all patient data locally on the hospital's own computer, ensuring no patient data is transmitted outside the institution's network.
Zio XT's cloud-based platform simplifies centralized data access and reporting for multi-site review, with device distribution being the primary logistical consideration. 1CMR Pro's on-premise deployment requires individual software installation and maintenance at each site, keeping data localized within that institution.
Zio XT boasts high patient compliance and satisfaction, suggesting rapid integration into patient care pathways for efficient arrhythmia detection. 1CMR Pro aims to provide faster and more consistent cardiac MRI analysis, potentially leading to quicker reporting times and improved diagnostic throughput.
Zio XT includes a patient-activated button for symptomatic event logging, which is integrated into the comprehensive report for physician review alongside AI analysis. 1CMR Pro offers transparent and editable AI-generated contours, allowing clinicians direct control to review and modify automated measurements.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.